Event Registration

Publications

Jim Cahill, PhD

Pavliv L, Cahill JF. Formulation and manufacturing. In: Evens RP, ed. Drug and biological development: from molecule to product and beyond. New York: Springer Science+Business Media, 2007:202-21.

Laura DiMichele, PhD

DiMichele LA, Hakim ZS, Sayers RL, Rojas M, Schwartz RJ, Mack CP, Taylor JM. Transient expression of FRNK reveals stage-specific requirement for focal adhesion kinase activity in cardiac growth. Circ Res. 2009;104(10):1201-8.

Hakim ZS, DiMichele LA, Rojas M, Meredith D, Mack CP, Taylor JM. FAK regulates cardiomyocyte survival following ischemia/reperfusion. J Mol Cell Cardiol. 2009;46(2):241-8.

Sundberg-Smith LJ, DiMichele LA, Sayers RL, Mack CP, Taylor JM. The LIM protein leupaxin is enriched in smooth muscle and functions as a serum response factor cofactor to induce smooth muscle cell gene transcription. Circ Res. 2008;102(12):1502-11.

Arnavaz Eduljee, MD

Ajani JA, Randolph Hecht J, Ho L, Baker J, Oortgiesen M, Eduljee A, Michaeli D. An open-label, multinational, multicenter study of G17DT vaccination combined with cisplatin and 5-fluorouracil in patients with untreated, advanced gastric or gastroesophageal cancer: the GC4 study. Cancer 2006;106:1908-16.

Diana Fordyce, PhD

Fordyce D, Pavliv L. Format and content of the Common Technical Document (CTD). In: Linberg, SE, ed. Expediting drug and biologics development: a strategic approach. Watham, Ma.: PAREXEL International, 2006:67-92.

Fordyce D, Truocchio SP, Whitney K. Assembling and filing the Common Technical Document. In: Linberg, SE, ed. Expediting drug and biologics development: a strategic approach. Watham, Ma.: PAREXEL International, 2006:289-297.

Kathy Grako, PhD

DeFife KM, Grako K, Cruz-Aranda G, Price S, Chantung R, Macpherson K, Khoshabeh R, Gopalan S, Turnell WG. Poly(ester amide) co-polymers promote blood and tissue compatibility. J Biomater Sci Polym Ed. 2009;20(11):1495-511.

Gomurashvili Z, Zhang H, Da J, Jenkins TD, Hughes J, Wu M, Lambert L, Grako K, DeFife K, MacPherson K, Vassilev V, Katsarava R, Turnell W. Chapter 2. From drug-eluting stents to biopharmaceuticals: poly(esteramide) a versatile new bioabsorbable biopolymer. In: Mahapatro A, Kulshrestha AS, eds. Polymers for biological applications, second edition. ACS Symposium Series. 2008;977:10-26.

William Lee, PhD

Regulatory Overview of Conducting Gene Therapy Clinical Trials in the United States, BioProcessing Journal, Vol 5, No 2, Summer 2006.

Allison Lehtinen, PhD

Freedman BI, Bowden DW, Ziegler JT, Langefeld CD, Lehtinen AB, Rudock ME, Lenchik L, Hruska KA, Register TC, Carr JJ. Bone morphogenetic protein 7 (BMP7) gene polymorphisms are associated with inverse relationships between vascular calcification and bone mineral density: the Diabetes Heart Study. Bone Miner Res. 2009 Oct;24(10):1719-27.

Rudock ME, Liu Y, Ziegler JT, Allen SG, Lehtinen AB, Freedman BI, Carr JJ, Langefeld CD, Bowden DW. Association of polymorphisms in cyclooxygenase (COX)-2 with coronary and carotid calcium in the Diabetes Heart Study. Atherosclerosis. 2009 Apr;203(2):459-65.

Lehtinen AB, Daniel KR, Shah S, Nelson MR, Ziegler JT, Freedman BI, Carr JJ, Herrington DM, Langefeld CD, Bowden DW. Relationship between genetic variants in myocardial sodium and potassium channel genes and QT interval duration in diabetes: the Diabetes Heart Study. Ann Noninvasive Electrocardiol. 2009 Jan;14(1):72-9.

Bowden DW, Lehtinen AB, Ziegler JT, Rudock M, Xu J, Wagenknecht LE, Herrington DM, Rich SS, Freedman BI, Carr JJ, Langefeld CD. Genetic epidemiology of subclinical cardiovascular disease in the Diabetes Heart Study. Ann Hum Genet. 2008 Sep;72(Pt 5):598-610.

Burdon KP, Lehtinen AB, Langefeld CD, Carr JJ, Rich SS, Freedman BI, Herrington DM, Bowden DW. Genetic analysis of the soluble epoxide hydrolase gene, EPHX2, in subclinical cardiovascular disease in the Diabetes Heart Study. Diab Vasc Dis Res. 2008 Jun;5(2):128-34.

Lehtinen AB, Newton-Cheh C, Ziegler JT, Langefeld CD, Freedman BI, Daniel KR, Herrington DM, Bowden DW. Association of NOS1AP genetic variants with QT interval duration in families from the Diabetes Heart Study. Diabetes. 2008 Apr;57(4):1108-14.

Black MH, Fingerlin TE, Allayee H, Zhang W, Xiang AH, Trigo E, Hartiala J, Lehtinen AB, Haffner SM, Bergman RN, McEachin RC, Kjos SL, Lawrence JM, Buchanan TA, Watanabe RM. Evidence of interaction between PPARG2 and HNF4A contributing to variation in insulin sensitivity in Mexican Americans. Diabetes. 2008 Apr;57(4):1048-56.

Palmer ND, Lehtinen AB, Langefeld CD, Campbell JK, Haffner SM, Norris JM, Bergman RN, Goodarzi MO, Rotter JI, Bowden DW. Association of TCF7L2 gene polymorphisms with reduced acute insulin response in Hispanic Americans. J Clin Endocrinol Metab. 2008 Jan;93(1):304-9.

Marga Oortgiesen, PhD

Ajani JA, Randolph Hecht J, Ho L, Baker J, Oortgiesen M, Eduljee A, Michaeli D. An open-label, multinational, multicenter study of G17DT vaccination combined with cisplatin and 5-fluorouracil in patients with untreated, advanced gastric or gastroesophageal cancer: the GC4 study. Cancer. 2006;106:1908-16.

Veronesi B, Oortgiesen M. The TRPV1 receptor: target of toxicants and therapeutics. Toxicol Sci. 2006;89:1-3.

Daniel Pharand, CA

Pharand, D. Those that adapt to change will survive. Biotechnology Focus. 2010;13(9):18-20.

Heschi Rotmensch, MD, MBA

Heschi Rotmensch. Israel - A Solid Track Record in Clinical Research . JCS Magazine, 9th March 2009.

Lisa Sanders, PhD

Sanders LR, Patel MK, Mahaffey JW. The Drosophila gap gene giant has an anterior segment identity function mediated through disconnected and teashirt. Genetics. 2008;179(1):441-53.

Carron Sher, MB, ChB

Rainier S, Sher C, Reish O, Thomas D, Fink JK. De novo occurrence of novel SPG3A/atlastin mutation presenting as cerebral palsy. Arch Neurol. 2006;63:445-7.

Tara Stephenson, PhD (published as Lovekamp-Swan)

Glendenning ML, Lovekamp-Swan T, Schreihofer DA. Protective effect of estrogen in endothelin-induced middle cerebral artery occlusion in female rats. Neurosci Lett. 2008;445(2):188-92.